Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
Beam is seeking a highly motivated Associate Director/Director, Gene Therapy Operations (Apheresis) to serve as a key member of the field-based Gene Therapy Operations team within Commercial Patient Operations working alongside the Key Account Management and Market Access Teams.
This role is responsible for the operational aspect of treatment center onboarding, patient coordination, apheresis support, and drug product delivery activities at assigned treatment centers. The Director will act as the primary field-based operational partner to treatment centers, ensuring a seamless, compliant, and high-quality patient and provider experience from scheduling through infusion.
This individual will play a critical role in supporting operational commercial readiness and execution for Beam’s lead asset, risto-cel, and will serve as a “boots-on-the-ground” operational leader driving consistency, quality, and performance across the treatment center network.
We are actively hiring for several positions across regions nationwide.
Responsibilities:
Treatment Center Onboarding & Qualification -
•
Lead operational on-site onboarding, training, and qualification of apheresis and treatment centers
8+ years of healthcare experience, including experience in cell & gene therapy or apheresis operations (title will be commensurate with the candidate’s overall years of relevant experience.)
Experience with autologous CGT products and SCD preferred
Skills & Capabilities -
•
Ability to operate independently in a field-based, highly matrixed environment
•
Strong problem-solving and escalation management skills
•
Excellent training, teaching, and clinical communication abilities
•
High attention to detail with a strong focus on quality and compliance
•
Patient-centric and customer-focused mindset
Additional Requirements
•
Willingness to travel >60% (field-based role)
•
Ability to support on-site activities at treatment centers, including apheresis and infusion days
Beam’s field team operates through an account-based pod model (a team structure that groups cross-functional specialists together to manage a specific segment of accounts from lead to close). The Director, Key Account Manager (KAM), owns the integrated account strategy, account plan, and overall account performance. The Director, Field Market Access owns access, reimbursement and payer engagement. The Associate Director/Director, Gene Therapy Operations (GTO) owns site operational readiness and apheresis and patient logistics executions. Each role and team is expected to work cross functionally while maintaining clear functional accountability.
Benefits
The salary range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, education, scope of job, internal comparisons, and market data.
Beam Pay Range
$185,000—$260,000 USD
The salary range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, education, scope of job, internal comparisons, and market data.